Group One Trading’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,500
Closed -$249K 8324
2022
Q4
$249K Buy
+7,500
New +$242K ﹤0.01% 3675
2022
Q3
Sell
-600
Closed -$18K 8553
2022
Q2
$18K Buy
+600
New +$16.2K ﹤0.01% 6384
2022
Q1
Sell
-200
Closed -$4K 9033
2021
Q4
$4K Sell
200
-16,800
-99% -$322K ﹤0.01% 7748
2021
Q3
$327K Sell
17,000
-17,800
-51% -$355K ﹤0.01% 4653
2021
Q2
$772K Buy
34,800
+20,200
+138% +$428K ﹤0.01% 3699
2021
Q1
$383K Buy
+14,600
New +$347K ﹤0.01% 4350
2020
Q4
Sell
-8,100
Closed -$138K 7198
2020
Q3
$138K Buy
8,100
+7,100
+710% +$138K ﹤0.01% 3946
2020
Q2
$23K Buy
+1,000
New +$14.5K ﹤0.01% 4774
2017
Q2
Sell
-300
Closed -$4K 5233
2017
Q1
$4K Sell
300
-1,100
-79% -$15.4K ﹤0.01% 4358
2016
Q4
$25K Sell
1,400
-5,900
-81% -$104K ﹤0.01% 3616
2016
Q3
$141K Buy
7,300
+5,300
+265% +$104K ﹤0.01% 2714
2016
Q2
$39K Buy
+2,000
New +$39.2K ﹤0.01% 3455
2015
Q4
Sell
-1,000
Closed -$17K 5217
2015
Q3
$17K Sell
1,000
-1,000
-50% -$18.3K ﹤0.01% 4117
2015
Q2
$37K Sell
2,000
-500
-20% -$9.27K ﹤0.01% 3726
2015
Q1
$48K Buy
2,500
+2,000
+400% +$37K ﹤0.01% 3390
2014
Q4
$8K Buy
+500
New +$8.58K ﹤0.01% 4313

Other funds holding VIVO

Group One Trading's VIVO Position: Q3 2021 in Review

Group One Trading sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 6,180 shares — an estimated $123K sold.

Group One Trading first reported a position in VIVO in Q3 2014 and held it in 13 quarters. The position peaked at $1.04M in Q3 2020. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.

  • Group One Trading reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
  • Group One Trading sold 6,180 Meridian Bioscience Inc shares in Q3 2021, an estimated $123K.
  • Group One Trading first reported a position in Meridian Bioscience Inc in Q3 2014 and held it in 13 quarters.
  • Group One Trading's Meridian Bioscience Inc position peaked at $1.04M in Q3 2020.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.

Based on Group One Trading's 13F filing for Q3 2021, filed 12 Nov 2021.